Different patterns of cytokeratin expression in Barrett's esophagus - What is beyond?

Pathology Research and Practice

Volumn 199, Issue 9, 2003, Pages 581-587

  Mandys, Václav ^a,b   Lukáš, Karel ^a   Revoltella, Roberto ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

Barrett's esophagus; Cytokeratins; Gastro esophageal junction; Immunohistochemistry

Indexed keywords

CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7; KERATIN ANTIBODY; PROTEIN SUBUNIT;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; GOBLET CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOWER ESOPHAGUS SPHINCTER; MOLECULAR WEIGHT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SAMPLING; SQUAMOUS EPITHELIUM; STOMACH GLAND; STOMACH MUCOSA;

EID: 0242351196     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00465     Document Type: Article

References (29)

1. Boch JA, Shields HM, Antonioli DA, Zwas F, Sawhney RA, Trier JS (1997) Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. Gastroenterology 112: 760-765
2. Cameron AJ, Lomboy CT, Pera M, Carpenter HA (1995) Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 109: 1541-1546
3. Chandrasoma PT, Lokuhetty DM, Demeester TR, Bremmner CG, Peters JH, Oberg S, Groshen S (2000) Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol 24: 344-351
4. Chandrasoma PT, Der R, Ma Y, Dalton P, Taira M (2000) Histology of the gastroesophageal junction. An autopsy study. Am J Surg Pathol 24: 402-409
5. Couvelard A, Cauvin J-M, Goldfain D, Rotenberg A, Robaskiewicz M, Flèjou J-F (2001) Cytokeratin immunoreactivity of intestinal metaplasia at normal esophagogastric junction indicates its aetiology. Gut 49: 761-766
6. De Meester SR, Wickramasinghe KS, Lord RV, Friedman A, Balaji NS, Chandrasoma PT, Hagen JA, Peters JH, De Meester TR (2002) Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM and Barrett's esophagus. Am J Gastroenterol 97: 2514-2523
7. Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 20: 1161-1181
8. El-Zimaity HMT, Graham DY (2001) Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol 96: 1378-1382
9. Glickman JN, Chen Y-Y, Wang HH, Antonioli DA, Odze RD (2001) Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol 25: 569-578
10. Goldblum JR (2002) The significance and etiology of intestinal metaplasia of the esophagogastric junction. Ann Diagn Pathol 6: 67-73
11. Iftikhar SY, James PD, Steele RJC, Hardcastle JD, Atkinson M (1992) Length of Barrett's esophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 33: 1155-1158
12. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, Young LS (1999) Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 154: 965-973
13. Jovanovic I, Tzardi M, Mouzas IA, Micev M, Pesko P, Milosavljevic T, Zois M, Sganzos M, Delides G, Kanavaros P (2002) Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction. Histol Histopathol 17: 445-454
14. Latchford A, Eksteen B, Jankowski J (2001) The continuing tale of cytokeratins in Barrett's mucosa: As you like it. Gut 49: 746-749
15. Mohammed IA, Streutker CJ, Riddell RH (2002) Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod Pathol 15: 611-616
16. Nomura S, Esumi H, Job C, Tan SS (1998) Lineage and clonal development of gastric glands. Dev Biol 204: 124-135
17. Odze R (2002) Cytokeratin 7/20 immunostaining: Barrett's esophagus or gastric intestinal metaplasia? The Lancet 359: 1711-1713
18. Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL (1999) Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia in the stomach. Hum Pathol 30: 288-294
19. Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, Gramlich TL (2000) Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 119: 683-690
20. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK (1976) The histologic spectrum of Barrett's esophagus. N Engl J Med 295: 476-480
21. Ried BJ, Weinstein WM (1987) Barrett's esophagus and adenocarcinoma. Annu Rev Med 38: 477-492
22. Schwerer MJ, Baczako K (1996) Expression of cytokeratins typical for ductal and squamous differentiation in the human stomach: an immunohistochemical study of normal foveolar epithelium, Helicobacter pylori gastritis and intestinal metaplasia. Histopathology 29: 131-137
23. Schwerer MJ, Baczako K (1996) Immunohistochemical evaluation of keratin 20 expression in intestinal metaplasia types I to III. J Clin Pathol 49: 791-794
24. Walner B, Sylvan A, Janunger KG, Bozoky B, Stenling R (2001) Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance. Scand J Gastroenterol 36: 910-915
25. Warson C, van de Bovenkamp JHB, Korteland-van Male AM, Buller HA, Einerhand AWC, Ectors NLEY, Dekker J (2002) Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Hum Pathol 33: 660-668
26. Weinstein WM, Ippoliti AF (1996) The diagnosis of Barrett's esophagus. Goblets, goblets, goblets. Gastrointest Endosc 44: 91-94
27. Wolf C, Timmer R, Breumelhof R, Seldenrijk CA, Smout AJPM (1999) Columnar lined esophagus and intestinal metaplasia: current concepts. Eur J Gastroenterol Hepatol 11: 793-800
28. Wright NA (2000) Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer. Int J Exp Pathol 81: 117-143
29. Zeng Z, Melamed J, Symmans PJ, Cangiarella JF, Shapiro RL, Peralta H, Symmans WF (1999) Benign proliferative nipple duct lesions frequently contain CAM 5.2 and anti-cytokeratin 7 immunoreactive cells in the overlying epidermis. Am J Surg Pathol 23: 1349-1355